Embla Medical hf. (CPH:EMBLA)
Denmark
· Delayed Price · Currency is DKK 32.60
-0.30 (-0.91%)
At close: Feb 21, 2025
Embla Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 68.28 | 58.39 | 42.51 | 63.99 | 6.21 | Upgrade
|
| Depreciation & Amortization | 49.4 | 43.33 | 43.49 | 45.54 | 42.2 | Upgrade
|
| Other Amortization | 6.58 | 6.59 | 5.87 | 5.99 | 5.93 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.12 | 16.57 | Upgrade
|
| Other Operating Activities | 2.37 | -2.88 | -11.82 | 6.5 | -1.96 | Upgrade
|
| Change in Accounts Receivable | -5.52 | -16.37 | -13.2 | -13.18 | 18.45 | Upgrade
|
| Change in Inventory | -5.93 | -2.27 | -28.62 | -15.78 | 12.75 | Upgrade
|
| Change in Accounts Payable | -2.28 | 14.9 | 10.94 | 7.76 | -7.91 | Upgrade
|
| Change in Other Net Operating Assets | 3.17 | -7.37 | 11.58 | -0.4 | - | Upgrade
|
| Operating Cash Flow | 116.07 | 94.32 | 60.77 | 100.53 | 92.24 | Upgrade
|
| Operating Cash Flow Growth | 23.05% | 55.21% | -39.55% | 8.99% | -3.19% | Upgrade
|
| Capital Expenditures | -27.03 | -29.23 | -16.55 | -16.96 | -13.77 | Upgrade
|
| Cash Acquisitions | -70.07 | -11.9 | -41.78 | -33.94 | -76.29 | Upgrade
|
| Sale (Purchase) of Intangibles | -12.19 | -13.05 | -9.4 | -9.73 | -10.25 | Upgrade
|
| Other Investing Activities | 4.53 | -2.97 | 1.47 | 1.18 | -6.14 | Upgrade
|
| Investing Cash Flow | -104.77 | -57.15 | -66.26 | -59.45 | -106.45 | Upgrade
|
| Long-Term Debt Issued | 39.79 | - | 101.42 | 1.69 | 98.3 | Upgrade
|
| Long-Term Debt Repaid | -24.38 | -40.2 | -87.06 | -51.44 | -30.63 | Upgrade
|
| Net Debt Issued (Repaid) | 15.41 | -40.2 | 14.36 | -49.74 | 67.67 | Upgrade
|
| Repurchase of Common Stock | - | - | -9.94 | - | -3.94 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -9.28 | Upgrade
|
| Other Financing Activities | -9.65 | -0.76 | -0.63 | -1.33 | -2.59 | Upgrade
|
| Financing Cash Flow | 5.76 | -40.96 | 3.79 | -51.07 | 51.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3.55 | -0.2 | -6.86 | -7.18 | 6.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | Upgrade
|
| Net Cash Flow | 13.51 | -3.98 | -8.57 | -17.17 | 43.75 | Upgrade
|
| Free Cash Flow | 89.03 | 65.09 | 44.22 | 83.57 | 78.47 | Upgrade
|
| Free Cash Flow Growth | 36.78% | 47.18% | -47.08% | 6.50% | 4.09% | Upgrade
|
| Free Cash Flow Margin | 10.41% | 8.28% | 6.15% | 11.63% | 12.47% | Upgrade
|
| Free Cash Flow Per Share | 0.21 | 0.15 | 0.11 | 0.20 | 0.19 | Upgrade
|
| Cash Interest Paid | 24.08 | 16.05 | 13.11 | 12.15 | 10.44 | Upgrade
|
| Cash Income Tax Paid | 23.49 | 20.35 | 19.66 | 16.3 | 16.94 | Upgrade
|
| Levered Free Cash Flow | 70.1 | 24.48 | 52.4 | 79.11 | 71.47 | Upgrade
|
| Unlevered Free Cash Flow | 84.63 | 35.7 | 59.4 | 85.23 | 77.48 | Upgrade
|
| Change in Net Working Capital | 3.81 | 28.4 | 8.18 | 1.67 | -18.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.